Cargando…
MicroRNA‐132‐3p inhibits tumor malignant progression by regulating lysosomal‐associated protein transmembrane 4 beta in breast cancer
Lysosomal‐associated protein transmembrane 4 beta (LAPTM4B), a proto‐oncogene, has been shown to be a positive modulator in cancer progression. However, the mechanism of LAPTM4B regulation is not fully elucidated. Aberrant microRNAs (miRNAs) can regulate gene expression by interfering with target tr...
Autores principales: | Li, Sha, Xu, Jian‐Jun, Zhang, Qing‐Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778625/ https://www.ncbi.nlm.nih.gov/pubmed/31389121 http://dx.doi.org/10.1111/cas.14164 |
Ejemplares similares
-
In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the Progression of Breast Cancer
por: Tao, Deyou, et al.
Publicado: (2019) -
Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2016) -
Molecular mechanisms of the microRNA-132 during tumor progressions
por: Moghbeli, Meysam, et al.
Publicado: (2021) -
MicroRNA-363-3p inhibits colorectal cancer progression by targeting interferon-induced transmembrane protein 1
por: Wang, Yun, et al.
Publicado: (2023) -
cAMP Responsive Element Binding Protein-1 Is a Transcription Factor of Lysosomal-Associated Protein Transmembrane-4 beta in Human Breast Cancer Cells
por: Zhang, Meng, et al.
Publicado: (2013)